A Case Control Study on the Contribution of Factor V-Leiden, Prothrombin G20210A, and MTHFR C677T Mutations to the Genetic Susceptibility of Deep Venous Thrombosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bertina RM, Koeleman BPC, Koster T, et~al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64–67.
Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995;85:1504–1508.
Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698–3703.
Tamim H, Finan RR, Almawi WY. Prevalence of two thrombophilia predisposing mutations: Factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese. Thromb Haemost 2002;88:691–692.
Zivelin A, Griffin JH, Xu X, et~al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 1997;89:397–402.
Almawi WY, Ameen G, Tamim H, Finan RR, Irani-Hakime N, Factor V. prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease. J Thrombosis Thrombolysis 2004;17:199–205.
Couturaud F, Oger E, Abalain JH, et~al. Methylenetetrahydrofolate reductase C677T genotype and venous thrombo-embolic disease. Respiration 2000;67:657–661.
Shmeleva VM, Kapustin SI, Papayan LP, Sobczynska-Malefora A, Harrington DJ, Savidge GF. Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia. Thromb Res 2003;111:351–356.
Ray JG, Shmorgun D, Chan, WS. Common C677T polymorphism of the methylene-tetrahydrofolate reductase gene and the risk of venous thromboembolism: Meta-analysis of 31 studies. Pathophysiol Haemost Thromb 2002;32:51–58.
Zalavras ChG, Giotopoulou S, Dokou E, et~al. Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece. Int Angiol 2002;21:268–271.
De Stefano V, Casorelli I, Rossi E, Zappacosta B, Leone G. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism. Semin Thromb Hemost 2000;26:305–311.
Morelli VM, Lourenco DM, D’Almeida V, et~al. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients. Blood Coagul Fibrinolysis 2002;13:271–275.
Keijzer MB, den Heijer M, Blom HJ, et~al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolate-reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 2002;88:723–728.
Gemmati D, Serino ML, Moratelli S, Tognazzo S, Ongaro A, Scapoli GL. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis. Haemostasis 2001;31:99–105.
Hatzaki A, Anagnostopoulou E, Metaxa-Mariatou V, et~al. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients. Int Angiol 2003;22:79–82.
Aznar J, Vaya A, Estelles A, et~al. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica 2000;85:1271–1276.
Emmerich J, Rosendaal FR, Cattaneo M, et~al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism–pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Thromb Haemost 2001;86:809–816.
Salomon O, Steinberg DM, Zivelin A, et~al. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment. Arterioscler Thromb Vasc Biol 1999;19:511–518.
Cattaneo M, Tsai MY, Bucciarelli P, et~al. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506). Arterioscler Thromb Vasc Biol 1997;17:1662–1666.
Fujimura H, Kawasaki T, Sakata T, et~al. Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia. Thromb Res 2000;98:1–8.
Rintelen C, Mannhalter C, Lechner K, et~al. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylene-tetrahydrofolate-reductase gene. Blood Coagul Fibrinolysis 1999;10:101–105.
Irani-Hakime N, Tamim H, Kreidy R, Almawi WY. The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese. Am J Hematol 2000;65:45–49.
Taher A, Khalil I, Shamseddine A, El-Ahdab F, Bazarbachi A. High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: Is the eastern Mediterranean region the area of origin of this mutation? Thromb Haemost 2001;86:723–724.
De Stefano V, Rossi E, Paciaroni K, et~al. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene. Haematologica 2003;88:61–66.
Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222–1231.
Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993;72:477–481.
Simioni P, Prandoni P, Lensing AW, et~al. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood 2000;96:3329–3333.
Lindmarker P, Schulman S, Sten-Linder M, Wiman B, Egberg N, Johnsson H. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of anticoagulation. Thromb Haemost 1999;81:684–689.
Folsom AR, Cushman M, Tsai MY, Heckbert SR, Aleksic N. Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration, and incidence of venous thromboembolism. Am J Hematol 2002;71:285–290.
Margaglione M, Brancaccio V, Giuliani N, et~al. Increased risk for venous thrombosis in carriers of the prothrombin G → A20210 gene variant. Ann Intern Med 1998; 129:89–93.
Vargas M, Soto I, Pinto CR, et~al. The prothrombin 20210A allele and factor V Leiden are associated with venous thrombosis but not with early coronary artery disease. Blood Coagul Fibrinolysis 1999;10:39–41.
Isotalo PA, Donnelly JG. Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis. Mol Diagn 2000;5:59–66.
Kluijtmans LA, den Heijer M, Reitsma PH, Heil SG, Blom HJ, Rosendaal FR. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb Haemost 1998;79:254–258.
Margaglione M, D’Andrea G, D’Addedda M, et~al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost. 1998;79:907–911.
Makris M, Preston FE, Beauchamp NJ, et~al. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost. 1997;78:1426–1429.
Howard TE, Marusa M, Boisza J, et~al. The prothrombin gene 3′-untranslated region mutation is frequently associated with factor V Leiden in thrombophilic patients and shows ethnic-specific variation in allele frequency. Blood 1998;91:1092.
Zama T, Murata M, Ono F, et~al. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals. Int J Haematol 1996;65:71–78.
Arruda VR, Annichino-Bizzacchi JM, Goncalves MS, Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997;78:1430–1433.
Rosendaal FR, Doggen CJM, Zivelin A, et~al. Geographic distribution of the 20210G to A prothrombin variant. Thromb Haemost 1998;79:706–708.